Tag: DK0010272202

news source company FOR content information 1 market business

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

Company Announcement

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for...

Media Release

COPENHAGEN, Denmark; June 15, 2025

Grant of Restricted Stock Units and Warrants to Employees in Genmab

Company Announcement

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Email

This field is for validation purposes and should be left unchanged.

HomeTagsDK0010272202